GEODE CAPITAL MANAGEMENT, LLC - SCICLONE PHARMACEUTICALS INC ownership

SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 142 filers reported holding SCICLONE PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 5.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of SCICLONE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$5,695,000
+19.9%
508,551
+17.7%
0.00%0.0%
Q2 2017$4,751,000
+17.3%
431,984
+4.5%
0.00%0.0%
Q1 2017$4,050,000
-5.5%
413,282
+4.2%
0.00%0.0%
Q4 2016$4,284,000
+11.5%
396,728
+5.8%
0.00%0.0%
Q3 2016$3,842,000
-15.0%
374,854
+8.3%
0.00%0.0%
Q2 2016$4,519,000
+20.9%
346,098
+1.8%
0.00%0.0%
Q1 2016$3,737,000
+23.4%
339,866
+3.2%
0.00%0.0%
Q4 2015$3,029,000
+33.3%
329,245
+0.5%
0.00%
+100.0%
Q3 2015$2,272,000
-35.5%
327,487
-8.8%
0.00%
-50.0%
Q2 2015$3,524,000
+6.9%
358,959
-3.6%
0.00%0.0%
Q1 2015$3,298,000
+8.1%
372,386
+6.9%
0.00%0.0%
Q4 2014$3,050,000
+2.1%
348,282
-19.7%
0.00%0.0%
Q3 2014$2,986,000
+119.4%
433,494
+67.4%
0.00%
+100.0%
Q2 2014$1,361,000
+17.3%
258,976
+1.5%
0.00%0.0%
Q1 2014$1,160,000
-7.1%
255,034
+2.9%
0.00%0.0%
Q4 2013$1,248,000
-6.2%
247,767
-5.6%
0.00%0.0%
Q3 2013$1,331,000
+15.0%
262,518
+12.5%
0.00%0.0%
Q2 2013$1,157,000233,2480.00%
Other shareholders
SCICLONE PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,663,281$16,300,0009.19%
Nantahala Capital Management 1,891,328$18,535,0002.06%
Nine Chapters Capital Management LLC 40,700$399,0000.54%
MENTA CAPITAL LLC 396,336$3,884,0000.38%
Sapphire Star Partners LP 30,439$298,0000.34%
TFS CAPITAL LLC 95,432$935,0000.30%
Ativo Capital Management LLC 123,428$1,210,0000.30%
GLG Partners LP 363,188$3,559,0000.17%
GSA CAPITAL PARTNERS LLP 240,013$2,352,0000.13%
Bowling Portfolio Management LLC 68,473$671,0000.11%
View complete list of SCICLONE PHARMACEUTICALS INC shareholders